Synthetic Biology Market Size

  • Report ID: 4810
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Synthetic Biology Market Outlook:

Synthetic Biology Market size was valued at USD 18.87 billion in 2025 and is set to exceed USD 142.42 billion by 2035, expanding at over 22.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of synthetic biology is estimated at USD 22.67 billion.

The market growth is mainly owing to the increasing demand for sustainable and renewable energy sources, rising investments in research and development activities, and advancements in synthetic biology technologies. Startups in the synthetic biology industry was noted to raise nearly USD 7.8 billion in investment in the year 2020 and USD 19 billion in the year 2021. Companies like Arbor Biotechnologies and DNA Script have each raised about USD 215 million and USD 168 million. The heavy investment is expected to increase the circulation of funds in the market and support the growth of the market throughout the supply chain.

In addition to this, rising demand for energy efficient systems coupled with increasing demand for sustainable and renewable energy sources is expected to fuel market growth in the near future. It was noted that global energy demand increased by 2.3% in the year 2019, with buildings and industry accounting for 80% of the increase. Energy efficiency improvements accounted for 40% of the reduction in global energy demand in the year 2019. Synthetic biology can be used to create biofuels and other renewable energy sources. This has been assessed as a key factor that is estimated to create lucrative opportunities for the synthetic biology market over the forecast period.


Synthetic Biology Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of synthetic biology is estimated at USD 22.67 billion.

The global synthetic biology market size crossed USD 18.87 billion in 2025 and is likely to expand at a CAGR of around 22.4%, surpassing USD 142.42 billion revenue by 2035.

North America synthetic biology market will hold over 35% share by 2035, growing genome-editing treatments and insurance coverage.

Key players in the market include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Danaher Corporation, GenScript Biotech Corporation, Twist Bioscience Corporation, Amyris, Inc., Intrexon Corporation, Synthetic Genomics Inc., Codexis, Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos